TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+7.13%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$181M
AUM Growth
+$181M
(+12%)
Cap. Flow
+$1.19M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
71.78%
Holding
42
New
6
Increased
12
Reduced
7
Closed
4
Top Buys
| 1 |
NXTM
NxStage Medical Inc.
NXTM
|
$6.66M |
| 2 |
NovoCure
NVCR
|
$6.29M |
| 3 |
QuidelOrtho
QDEL
|
$5.2M |
| 4 |
Quest Diagnostics
DGX
|
$4.93M |
| 5 |
McKesson
MCK
|
$3.9M |
Top Sells
| 1 |
Nektar Therapeutics
NKTR
|
$26.6M |
| 2 |
CVS Health
CVS
|
$6.1M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$4.17M |
| 4 |
Steris
STE
|
$3.94M |
| 5 |
Dentsply Sirona
XRAY
|
$2.99M |
Sector Composition
| 1 | Healthcare | 92.93% |
| 2 | Industrials | 3.28% |
| 3 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Baxter International
BAX
$12.7B
| – | – |
0
| – | – |
|
27
Boston Scientific
BSX
$156B
| – | – |
0
| – | – |
|
|
28
CVS Health
CVS
$92.8B
| – | – |
-75,000
| Closed | -$6.1M |
|
29
Evolent Health
EVH
$1.12B
| – | – |
-75,000
| Closed | -$1.34M |
|
30
HCA Healthcare
HCA
$94.5B
| – | – |
0
| – | – |
|
31
iShares S&P 100 ETF
OEF
$22B
| – | – |
0
| – | – |
|
32
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – |
0
| – | – |
|
33
Stryker
SYK
$150B
| – | – |
0
| – | – |
|
34
Thermo Fisher Scientific
TMO
$186B
| – | – |
0
| – | – |
|
35
Health Care Select Sector SPDR Fund
XLV
$33.9B
| – | – |
0
| – | – |
|
|
36
Dentsply Sirona
XRAY
$2.85B
| – | – |
-50,000
| Closed | -$2.99M |
|
|
SIEN
37
DELISTED
Sientra, Inc.
SIEN
| – | – |
-60,000
| Closed | -$924K |
|
|
ESRX
38
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
0
| – | – |
|
|
ALR
39
DELISTED
Alere Inc
ALR
| – | – |
0
| – | – |
|
|
SHPG
40
DELISTED
Shire pic
SHPG
| – | – |
0
| – | – |
|
41
Henry Schein
HSIC
$8.44B
| – | – |
0
| – | – |
|
42
iShares Russell 2000 ETF
IWM
$67B
| – | – |
0
| – | – |
|